The specificity of this blocking antibody has been well-characterized in our previous studies, in which we showed that blocking the activity of MT1-MMP with this antibody effectively promotes body weight loss in obesity, improves metabolic functions in diabetes, and promotes viral clearance in SARS-CoV-2-infected mice13,15–17. Here, MMP14 is linked to obesity disorder.